Results 131 to 140 of about 21,293 (203)

Development of a Semi-Mechanistic Population Pharmacokinetic Model for Predicting Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Exposure in Plasma and Cellular Matrices During Pregnancy and Postpartum. [PDF]

Clin Pharmacokinet
Yu Y, Brooks KM, Doncel GF, Best BM, Marzinke MA, Mirochnick M, Anderson P, Myer L, Celum C, Heffron R, Coleman J, Davey DJ, Hendrix CW, Momper JD, Bies R, Scott RK.   +15 more
europepmc   +1 more source

Comparative Efficacy and Renal Safety of Entecavir and Tenofovir Disoproxil Fumarate in the Treatment of Chronic Hepatitis B: A Retrospective Cohort Study From Vietnam. [PDF]

Pharmacol Res Perspect
Vo TD, Nguyen HNG, Phan ST.
europepmc   +1 more source

Simultaneous Quantification of Doravirine, Lamivudine, and Tenofovir Disoproxil Fumarate in Human Plasma by UPLC-MS/MS: Method Development and Validation. [PDF]

Turk J Pharm Sci
Kanjarla N, Katta B.
europepmc   +1 more source

Microbicide Vaginal Rings: Technological Challenges and Clinical Development [PDF]

, 2016
Boyd, Peter J., Malcolm, R. Karl, McCoy, Clare F., Murphy, Diarmaid J.   +3 more
core   +1 more source

Pegylated interferon-α-2b add-on therapy to renal function for chronic hepatitis B patients who were treated with tenofovir disoproxil fumarate: a retrospective real-world study. [PDF]

Virol J
Wang TB, Li AH, Zhuo Y, Wu HJ, Yue MQ, Wang YP, Wang XH.   +6 more
europepmc   +1 more source

The blocking efficacy and safety of tenofovir disoproxil fumarate tablets on mother-to-child transmission in pregnant women with high serum HBV DNA load: a retrospective cohort study. [PDF]

BMC Pregnancy Childbirth
Wei Q, Song L, Song S, Zhang X, Qi X, Li K, Wang S, Liang Q.   +7 more
europepmc   +1 more source

Evaluation of pharmacokinetic interactions between long-acting cabotegravir or emtricitabine/tenofovir disoproxil fumarate and hormonal contraceptive agents: a tertiary analysis of South African participants in HPTN 084. [PDF]

J Int AIDS Soc
Marzinke MA, Hanscom B, Haines D, Scarsi KK, Agyei Y, Piwowar-Manning E, Hendrix CW, Gollings R, Rose S, Mathew C, Panchia R, Spooner E, Singh N, Bock P, Rinehart AR, Ford SL, Rooney JF, Soto-Torres L, Cohen MS, Hosseinipour MC, Delany-Moretlwe S, HPTN 084 Study Team.   +21 more
europepmc   +1 more source

Correspondence to editorial on "Switching to besifovir in patients with chronic hepatitis B receiving tenofovir disoproxil fumarate: A randomized trial". [PDF]

Clin Mol Hepatol
Yim HJ, Kang SH, Jung YK, Yang JM.
europepmc   +1 more source

Severe Osteomalacia in an Adult HIV Patient on Tenofovir Disoproxil Fumarate. [PDF]

Indian J Nephrol
Machiraju S, Sridevi KVVS, Boddapati NR, Ravishankar MS.   +3 more
europepmc   +1 more source

Tenofovir amibufenamide in chronic hepatitis B: Lipid changes and 144-week safety with tenofovir disoproxil fumarate-to-tenofovir amibufenamide switch. [PDF]

World J Gastroenterol
Zeng ZH, Liu JQ, Zhang M, Qiu CL, Xu ZY.
europepmc   +1 more source